Publications & Works

Published journal articles indexed by SCI, SSCI, and AHCI

Articles Published in Other Journals

Refereed Congress / Symposium Publications in Proceedings

Çoklu Primer Tümörlerde Primer ve İkincil Tümörlerin Özelliklerinin İncelenmesi

16-20 Eylül 2023 (4.Uluslararası 8.Ulusal) İlaç ve Tedavi Kongresi, KKTC, Cyprus (Kktc), 16 September - 20 October 2023

MEME KANSERİNDE ATİPİK PREZENTASYON, OLGU SUNUMU

26-30 NİSAN 2023 10. TÜRK TIBBİ ONKOLOJİ KONGRESİ, Turkey, 26 - 30 April 2023

MEME KANSERİNDE NADİR BİR PARANEOPLASTİK SENDROM, OLGU SUNUMU

26-30 NİSAN 2023 10. TÜRK TIBBİ ONKOLOJİ KONGRESİ, Ankara, Turkey, 26 - 30 April 2023

BRCA MUTASYONLU HASTALARIN KLİNİKOPATOLOJİK ÖZELLİKLERİ

8. TÜRK TIBBİ ONKOLOJİ KONGRESİ, Antalya, Turkey, 3 - 07 November 2021, no.187, pp.112 Sustainable Development

Geç tanı alan bir melanom olgusu

13-17 EKİM 2021 5. ULUSAL İMMÜNOTERAPİ VE ONKOLOJİ KONGRESİ, Antalya, Turkey, 13 - 17 October 2021

Dabrafenib+trametinibe bağlı grade 4 nötropeni olgusu

5. Ulusal İmmunoterapi ve Onkoloji Kongresi, Antalya, Turkey, 13 - 17 October 2021, pp.20

Geç tanı alan bir melanom olgusu

5. Ulusal İmmunoterapi ve Onkoloji Kongresi, Antalya, Turkey, 13 - 17 October 2021, pp.10-11 Creative Commons License

Perioperative FLOT: Tolerability, pathological response rates, and the role of adjuvant phase

ESMO 22nd World Congress on Gastrointestinal Cancer, ELECTR NETWORK, 1 - 04 July 2020, vol.31 identifier

The effect of chemotherapy on survival applied in the last term of life in cancer patients

10th Eurasian Hematology Oncology Congress, İstanbul, Turkey, 8 - 11 October 2019, vol.85 Sustainable Development identifier

Real life data from Turkey regarding the impact of first-line sunitinib and pazopanib in metastatic renal cell cancer.

Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, United States Of America, 31 May - 04 June 2019, vol.37 Sustainable Development identifier

Metastatik Renal Hücreli Karsinom Tek Merkez Deneyimi

2. Ulusal Ürogenital Kanserler Kongresi, Turkey, 11 - 14 October 2018

NGS based ctDNA-liquide biopsy analysis in Turkish Cancer patients

5th Central-Eastern European Congresson Cell-Free Nucleic Acids, 21 - 22 June 2018 Sustainable Development

PRİMER İNCE BARSAK MALİGN MELANOM OLGUSU

7. TÜRK TIBBİ ONKOLOJİ KONGRESİ, Turkey, 21 - 25 March 2018

Results of observational study to determine K-ras mutation rates in 2458 patients with metastatic colorectal cancer in Turkey (TURKRAS Study).

Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) / Clinical Science Symposium on Predicting and Improving Adverse Outcomes in Older Adults with Cancer, Illinois, United States Of America, 29 May - 02 June 2015, vol.33 Sustainable Development identifier

Interim results of observational study to determine K-ras mutation rates in patients with metastatic colorectal cancer in Turkey (TURKRAS study)

European Cancer Congress 2013 - 17th ECCO / 38th ESMO / 32nd ESTRO, Amsterdam, Netherlands, 27 September - 01 October 2013, vol.49 Sustainable Development identifier

Evaluation of anthracycline incuced cardiotoxicity by speckle tracking echocardiography.

Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, United States Of America, 31 May - 04 June 2013, vol.31 identifier

THE PERCENTAGE OF CD44-/CD24-/LIN- CELLS IN PRIMARY BREAST TUMORS AND CORRELATION BETWEEN PROGNOSTIC FACTORS

37th Congress of the European-Society-for-Medical-Oncology (ESMO), Vienna, Austria, 28 September - 02 October 2012, vol.23, pp.110-111 identifier

A COMPARISON OF XELIRI PLUS BEVACIZUMAB WITH FOLFIRI PLUS BEVACIZUMAB AS FIRST-LINE SETTING IN PATIENTS WITH METASTATIC COLORECTAL CANCER

14th World Congress on Gastrointestinal Cancer of the European-Society-for-Medical-Oncology (ESMO), Barcelona, Spain, 27 - 30 June 2012, vol.23, pp.98-99 Sustainable Development identifier

The prognostic value of beta-catenin and LEF-1 expression in patients with gastric carcinoma.

48th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, United States Of America, 1 - 06 June 2012, vol.30 identifier

Altered Mental Status of Cancer Patients in the Emergency Department

The Sixth Mediterrenean Emergency Medicine Congress (MEMC VI), 10 - 14 September 2011 Sustainable Development

Factors related with recurrence after complete pathologic response to post- operative chemotherapy in patients with epithelial ovarian cancer

31st Congress of the European-Society-for-Medical-Oncology, İstanbul, Turkey, 29 September - 03 October 2006, vol.17, pp.174 Sustainable Development identifier

Second line chemotherapy in non-small-cell lung carcinoma: A single-institution experience

31st Congress of the European-Society-for-Medical-Oncology, İstanbul, Turkey, 29 September - 03 October 2006, vol.17, pp.239 identifier

The treatment results of patients with extrapulmoner and pulmoner small cell cancer

31st Congress of the European-Society-for-Medical-Oncology, İstanbul, Turkey, 29 September - 03 October 2006, vol.17, pp.240 Sustainable Development identifier

Trastuzumab beyond progression in metastatic breast cancer

31st Congress of the European-Society-for-Medical-Oncology, İstanbul, Turkey, 29 September - 03 October 2006, vol.17, pp.77 Sustainable Development identifier

Brain metastases occurrence among metastatic breast cancer: A single oncology center experience.

41st Annual Meeting of the American-Society-of-Clinical-Oncology, Florida, United States Of America, 13 - 17 May 2005, vol.23 Sustainable Development identifier

Metrics

Publication

130

Citation (WoS)

901

H-Index (WoS)

15

Citation (Scopus)

1017

H-Index (Scopus)

16

Citation (Scholar)

119

H-Index (Scholar)

4

Citiation (TrDizin)

5

H-Index (TrDizin)

1

Project

1

Thesis Advisory

9

Open Access

9
UN Sustainable Development Goals